Amgen to invest $600M in new science and innovation center
Biotech giant Amgen on Sept. 2 announced plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks.
The center is designed to bring together researchers, engineers, and scientists across disciplines to enhance collaboration and accelerate the discovery of next-generation therapeutics for patients with the most serious diseases, the company said in a press release.
“At Amgen, we’re continuing to invest in the future of American science and innovation,” said Robert Bradway, the global firm’s chairman and CEO.
“This new center will empower our scientists with the tools and collaborative environment they need to shape the next era of scientific discovery and advance medicines that improve human health,” he said.
The building will feature advanced automation and digital capabilities, empowering scientists with the tools and environment needed to drive scientific excellence and advancements in biotechnology, according to the company.
Construction is expected to begin in Q3 2025 and create hundreds of U.S. jobs.
